Chinese Cancer Drugmakers Raise Global Stakes With Record Oncology Congress ShowingYicai·Oct 28, 2026 at 11:53 AMHCM-2.24%HAWG-0.82%
Lepu Biopharma's CMG901 improves overall survival in Phase III gastroesophageal cancer trialPUBT·Oct 26, 2026 at 08:31 AM02157-1.34%
Weekly Recap | LEPU BIO +11.08%, outperforming Hang Seng by 15.6 pointsWeekly Review·Oct 24, 2026 at 05:17 AM02157-1.34%
Hong Kong Healthcare Sector Reboots: Strategic Buybacks and Innovation Drive Divergent GrowthGlobal Report·Oct 22, 2026 at 10:14 AM02157-1.34%03309-3.57%
A 16x Stock, a Golf Maker Filed Under Logistics, and Hong Kong's 'Other' PileGlobal Report·Oct 13, 2026 at 10:51 AM00679+3.28%00361+2.70%